|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 31, 2017 ) Metabolic disorders drugs market covers medications that are used in the treatment of diseases such as diabetes, thyroid, hyperparathyroidism, hypopituitarism, hypoadrenalism and other metabolic diseases. Some of the major drugs used in the treatment metabolic diseases are Lantus (type 1 and 2 diabetes), Januvia (diabetes), and other drugs.
For more information about this report at http://www.reportsweb.com/metabolic-disorders-drugs-market-global-report-2017
The global metabolic disorders drugs market was estimated to be around $80 billion as of 2016. The metabolic disorders drugs market made up around 7% of the overall pharmaceuticals market in 2016. The metabolic disorders drugs market was the seventh largest market in the global pharmaceutical market in 2016.
Acquisitions
Strategic acquisitions of small companies by market leaders in the market to strengthen their market position is one of the major trend in the market. For instance, in August 2015 Novo Nordisk acquired Calibrium LLC and MB2 LLC, a US based biopharmaceutical research companies. Through the acquisitions Novo Nordisk focuses on expanding its obesity and diabetes product line by integrating Calibrium LLC and MB2 LLC companies.
Request a sample copy at http://www.reportsweb.com/inquiry&RW0001890206/sample
Table of Content
1. Metabolic Disorders Drugs Market Characteristics
2. Metabolic Disorders Drugs Market Size And Growth
3. Pestle Analysis
4. Metabolic Disorders Drugs Market Customer Information
5. Metabolic Disorders Drugs Market Segmentation
6. Metabolic Disorders Drugs Market Regional And Country Analysis
7. Global Metabolic Disorders Drugs Market Comparison With Macro Economic Factors
8. Metabolic Disorders Drugs Market Comparison With Macro Economic Factors Across Countries
9. Metabolic Disorders Drugs Market Comparison With Industry Metrics
10. Asia-Pacific Metabolic Disorders Drugs Market
11. Western Europe Metabolic Disorders Drugs Market
12. Eastern Europe Metabolic Disorders Drugs Market
13. North America Metabolic Disorders Drugs Market
14. South America Metabolic Disorders Drugs Market
15. Middle East Metabolic Disorders Drugs Market
16. Africa Metabolic Disorders Drugs Market
17. Metabolic Disorders Drugs Market Competitive Landscape
18. Key Mergers And Acquisitions In The Metabolic Disorders Drugs Market
19. Market Background: Pharmaceutical Drugs Market
20. Pharmaceuticals Industry Financial Margins
21. Appendix
Companies Mentioned
Anti-Diabetics
Anti-Thyroid Drugs
Others (Hyperparathyroidism, Hypopituitarism, Hypoadrenalism)
Inquire for Report at http://www.reportsweb.com/inquiry&RW0001890206/buying
ReportsWeb.com
Rajat Sahni
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
